Skip to main content Accessibility help
×
Hostname: page-component-7479d7b7d-qs9v7 Total loading time: 0 Render date: 2024-07-08T17:34:43.604Z Has data issue: false hasContentIssue false

Ch. 16 - Conclusion: Future Trends in Fillers

Published online by Cambridge University Press:  26 February 2010

Neil S. Sadick
Affiliation:
Cornell University, New York
Get access

Summary

The present treatise has outlined the major advances in the development and utilization of fillers in the United States. Fillers are playing an ever-expanding role within this clinical setting. Combination programs employing toxins, fillers, light source, and radiofrequency technologies make up the backbone of noninvasive photorejuvenation programs. The therapeutic armentarium of fillers available in this country continues to evolve annually. There are six major trends in next-generation fillers that have evolved in this regard. A well-accepted and standardized classification schema of these agents has yet to be evolved.

LONGER ACTING FILLING AGENTS

There is definitely a trend toward longer acting fillers. In our busy world and for economic reasons, individuals would like to minimize the number of filler treatments that are necessary while still maintaining effect. The major question that is not universally accepted is what is that optimal duration of effect? Most physicians feel that an intermediate-acting filler with duration of twelve to eighteen months is optimal. This allows for longevity greater than older generation collagens and traditional hyaluronic acid derivatives; however, if there are adverse sequelae, it will resolve within a reasonable period of time, although one may expect as we move down the road that this timeline may continue to expand.

SITE-SPECIFIC FILLERS

Another major trend in fillers is specific capabilities. This means that they have clinical and physical characteristics that are uniquely beneficial for given anatomic areas. Examples of such site-specific areas are the lips and tear troughs, where lighter fillers with greater laminar flow characteristics would be more beneficial.

Type
Chapter
Information
Augmentation Fillers , pp. 149 - 152
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Goldman, MP. Optimizing the use of fillers for facial rejuvenation: the right tool for the right job. Cosmet Dermatol. 2007; 20(7): S3 14–25.Google Scholar
Sadick, NS. Soft tissue augmentation: selection, mode of operation and proper use of injectable agents. Cosmet Dermatol. 2007; 20(5): S2 8–13.Google Scholar
Sadick, NS, Karcher, C, Palmisano, L. Cosmetic dermatology of the aging face. Clin Dermatol. 2009 (in press).CrossRefGoogle Scholar
Kaufman, MR, Miller, TA, et al. Autologous fat transfer for facial recontouring: is there science behind the art?Plast Reconst Surg. 2007; 119: 2287–2296.CrossRefGoogle ScholarPubMed
Vleggaar, D. Facial volumetric correction with injectable poly-L-lactic acid. Dermatol Surg. 2005; 31: 1511–1518.CrossRefGoogle ScholarPubMed
Dayan, SH. Bassichis, BA. Facial dermal fillers: selection of appropriate products and techniques. Aesthet Surg J. 2008; 28: 335–347.CrossRefGoogle ScholarPubMed
Keni, SP, Sidle, DM. Sculptra (injectable poly-L-lactic acid). Facial Plast Surg. 2007; 15: 91–97.CrossRefGoogle Scholar
Wang, F. Garza, , et al. In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injected into photodamaged human skin. Arch Dermatol. 2007; 143: 155–163.CrossRefGoogle ScholarPubMed
Holzapfel, A, Mangat, D, Barron, D. Soft-tissue augmentation with calcium hydroxylapatite. Arch Facial Plast Surg. 2008; 10: 335–338.CrossRefGoogle ScholarPubMed
Solakoglu, S, Tiryaki, T, Ciloglu, SE. The effect of cultured autologous fibroblasts on longevity of cross-linked hyaluronic acid used as a filler. Aesthet Surg J. 2008; 28: 412–416.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×